HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM

June 15, 2021 updated by: Chun Hao, Sun Yat-sen University

The Effectiveness of HIV Results Exchange Mechanism on Promoting Testing Behavior Among Men Who Have Sex With Men: A Cluster Randomized Controlled Trial

This will be a two-arm cluster randomized controlled trial. The control group can share their Center for Disease Control and Prevention certified online HIV results (COHIV) with another party freely through a social networking tool, while the intervention group will be asked for the COHIV before he can see the COHIV of his friend. The investigators hypothesize that the requires exchange will promote HIV testing and thus reduce HIV incidence among MSM.

Study Overview

Detailed Description

This will be a two-arm cluster randomized controlled trial. A WeChat-based mini program has been developed to send and receive Center for Disease Control and Prevention certified online HIV results (COHIV). WeChat is the ubiquitous communication and social networking tool in China. We will use the social network method for participant recruitment. A social network consists of one ego and some alters, and in this study a social network will be considered as a cluster. In a social network, ego is the MSM who shares his certified HIV test results with or without exchange mechanism by the WeChat mini program, while alters are recipients of the shared links. So the ego can shares his COHIV with many alters. After an ego shares the certified HIV test result with exchange mechanism (intervention group) or without exchange mechanism (control group) with their WeChat contactors, the people who click the link will be candidate alters in our study. 1020 alters will be recruited as the participants and the randomization would be based on the unit of social network, which means the alters will be randomized into the same group that the ego is in.

Participants in the intervention group will receive his friend's COHIV and can only open it when the participants share their own in exchange. If the participant already has the COHIV, the system will lead the user to send his COHIV to the friend. If the participant does not have the COHIV, the system will guide him to make online appointment at the testing clinic. The participants in the control group will be able to receive and open the friend's COHIV entirely at the friend's discretion without the mandatory exchange requirement. The system will also guide users on how to get an HIV test by making appointments with the MSM friendly clinics in the mini program. Questionnaires are scheduled at baseline, month 3, 6 and 9. Follow-up questionnaires will be delivered through WeChat. The primary outcome is HIV testing rate of the participants in the past three months.

Study Type

Interventional

Enrollment (Anticipated)

1008

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510060
        • Recruiting
        • Lingnan Partner Community Support Centre
        • Contact:
          • Jie Lu
          • Phone Number: 02013760745376

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Aged more than18 years old
  • Had anal sex with men
  • HIV unknown or negative
  • Plan to live in Guangzhou for the next year

Exclusion Criteria:

- Cannot complete questionnaire survey due to difficulty in reading or communication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Men will be required to exchange the Center for Disease Control and Prevention certified online HIV results (COHIV) with friends conditionally.
A WeChat-based mini program has been developed to send and receive Center for Disease Control and Prevention certified online HIV results (COHIV). WeChat is the ubiquitous communication and social networking tool in China. Participants in the intervention group will receive his friend's COHIV only when the participants share their own in exchange. If the participant already has the COHIV, the system will lead the user to send his COHIV to the friend. If the participant does not have the COHIV, the system will guide him to make online appointment at the testing clinic.
Active Comparator: Control group
Men will share the Center for Disease Control and Prevention certified online HIV results (COHIV) with friends freely without conditional exchange requirement.
The participants in the control group will be able to receive the friend's Center for Disease Control and Prevention certified online HIV results (COHIV) entirely at the friend's discretion without the mandatory exchange requirement. The system will also guide users on how to get an HIV test by making appointments with the MSM friendly clinics in the mini program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with self-reported HIV testing in the past three months
Time Frame: Enrollment time
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
Enrollment time
Number of participants with self-reported HIV testing in the past three months
Time Frame: 3 months after enrollment
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
3 months after enrollment
Number of participants with self-reported HIV testing in the past three months
Time Frame: 6 months after enrollment
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
6 months after enrollment
Number of participants with self-reported HIV testing in the past three months
Time Frame: 9 months after enrollment
Self-reported HIV testing includes any classification of HIV testing, will be measured by self-reported data from online questionnaires.
9 months after enrollment
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: Enrollment time
HIVST will be measured by self-reported data from online questionnaires.
Enrollment time
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 3 months after enrollment
HIVST will be measured by self-reported data from online questionnaires.
3 months after enrollment
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 6 months after enrollment
HIVST will be measured by self-reported data from online questionnaires.
6 months after enrollment
Number of participants with self-reported HIV self-testing(HIVST) in the past three months
Time Frame: 9 months after enrollment
HIVST will be measured by self-reported data from online questionnaires.
9 months after enrollment
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: Enrollment time
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
Enrollment time
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 3 months after enrollment
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
3 months after enrollment
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 6 months after enrollment
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
6 months after enrollment
Number of participants with clinic-based HIV testing services (HTS) in the past three months
Time Frame: 9 months after enrollment
Clinic-based HTS will be measured by the objectively recorded HIV testing at the HIV clinic which will be captured real-time through the computer system.
9 months after enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: Enrollment time
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
Enrollment time
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 3 months after enrollment
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
3 months after enrollment
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 6 months after enrollment
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
6 months after enrollment
Number of participants with sexually transmitted diseases (STDs) testing
Time Frame: 9 months after enrollment
Sexually transmitted diseases (STDs) testing will be measured by self-reported data from online questionnaires and registered data in the HIV testing system.
9 months after enrollment
Sexual behaviors in the past three months
Time Frame: Enrollment time
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
Enrollment time
Sexual behaviors in the past three months
Time Frame: 3 months after enrollment
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
3 months after enrollment
Sexual behaviors in the past three months
Time Frame: 6 months after enrollment
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
6 months after enrollment
Sexual behaviors in the past three months
Time Frame: 9 months after enrollment
High-risk and protective sexual behaviors include regular or casual sex partners; request for disclosure of HIV status before sex in the past 3 months; unprotected anal intercourse (UAI) with sex partners in the past 3 months; HIV testing service appointment and HIV test results, will be measured by self-reported data from online questionnaires and the routinely collect data in the HIV testing service system.
9 months after enrollment
HIV testing norms
Time Frame: Enrollment time
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys. All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
Enrollment time
HIV testing norms
Time Frame: 3 months after enrollment
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys. All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
3 months after enrollment
HIV testing norms
Time Frame: 6 months after enrollment
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys. All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
6 months after enrollment
HIV testing norms
Time Frame: 9 months after enrollment
HIV testing norms are measured using six survey items that are each on a four-point Likert scale in online surveys. All six items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate less positive HIV testing social norms.
9 months after enrollment
HIV stigma
Time Frame: Enrollment time
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future. All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
Enrollment time
HIV stigma
Time Frame: 3 months after enrollment
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future. All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
3 months after enrollment
HIV stigma
Time Frame: 6 months after enrollment
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future. All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
6 months after enrollment
HIV stigma
Time Frame: 9 months after enrollment
HIV stigma will be measured by a 7-item version of the HIV stigma scale, designed to measure the extent to which participants anticipated negative interpersonal and interpersonal consequences were they to contract HIV in the future. All seven items were rated on a Likert-type scale (1=Strongly Disagree; 4=Strongly Agree). The mean score is reported, ranged from 1 to 4. Higher values indicate greater stigma.
9 months after enrollment
Risk perception of HIV in MSM community
Time Frame: Enrollment time
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
Enrollment time
Risk perception of HIV in MSM community
Time Frame: 3 months after enrollment
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
3 months after enrollment
Risk perception of HIV in MSM community
Time Frame: 6 months after enrollment
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
6 months after enrollment
Risk perception of HIV in MSM community
Time Frame: 9 months after enrollment
Risk perception of HIV in MSM community will be measured by self-perceived HIV prevalence in the circle.
9 months after enrollment
HIV report delivery
Time Frame: Enrollment time
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service. These data will be collected by the WeChat-based data portal.
Enrollment time
HIV report delivery
Time Frame: 3 months after enrollment
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service. These data will be collected by the WeChat-based data portal.
3 months after enrollment
HIV report delivery
Time Frame: 6 months after enrollment
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service. These data will be collected by the WeChat-based data portal.
6 months after enrollment
HIV report delivery
Time Frame: 9 months after enrollment
HIV report delivery includes the proportion of Egos who forward and read their reports; the proportion of Alters who receive and read egos' reports; the proportion of alters who get their own HIV reports; the proportion of forwarded report usage among MSM and the satisfaction of online HIV report service. These data will be collected by the WeChat-based data portal.
9 months after enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Chun Hao, PhD, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2019

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

June 9, 2019

First Submitted That Met QC Criteria

June 11, 2019

First Posted (Actual)

June 12, 2019

Study Record Updates

Last Update Posted (Actual)

June 21, 2021

Last Update Submitted That Met QC Criteria

June 15, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The individual participant data that underlie the results in the published article would be available from the principal investigator on reasonable request.

IPD Sharing Time Frame

Beginning 9 months and ending 36 months following article publication.

IPD Sharing Access Criteria

Researchers who provide a methodologically sound proposal.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV/AIDS

Clinical Trials on COHIV with exchange mechanism

Subscribe